MedscapeLIVE! posts peer-to-peer learning events in person and virtually. These live experiences create a collaborative & engaging community for HCPs worldwide.
Global
- Tweets 10,134
- Following 700
- Followers 17,786
- Likes 741
🎯 Strengthen anti-TNF management in IBD. 📈 Explore how steady-state drug levels shape clinical and endoscopic outcomes, apply STRIDE-II targets 🧭 and use TDM to assess secondary loss of response. 🔬 mdsc.pe/4ctXzRB
67
🧩 IBS-C affects more than the gut. Uncover its impact on daily life, explore practical lifestyle strategies 🌿 and choose prescription treatments tailored to each patient’s priorities. 🎯 mdsc.pe/4gbThPC
72
😴➡️⚡ What’s next in narcolepsy type 1? Explore how orexin receptor agonists differ from traditional wake-promoting agents, review the latest clinical data 🔬 & sharpen your approach to NT1 diagnosis. 🧠 Stay ahead of emerging science—register today! mdsc.pe/45QnuiD
#NT1
59
QUIZ SHOW!🫀HF care is evolving—are you keeping pace? Explore the⚡latest evidence for nsMRAs across the HF spectrum, navigate safety and monitoring in impaired renal function, and integrate therapy into patient-centered GDMT. 🔬 Advance your HF strategy! mdsc.pe/4h1fron
81
🔬 Look beyond symptoms to rethink menopause management. Discover how phenotype-based frameworks and neuroendocrine insights 🌿 can guide care and help identify patients who may benefit from neurokinin receptor antagonists. mdsc.pe/4yglWKI #AAFPFMX
90
💻 AI is already changing clinical practice. 🤖 At #ODAC, 🔎 discover practical ways dermatologists can integrate AI into the modern clinic with insights from experts who understand the opportunities and challenges. mdsc.pe/4A59Bux
80
📚 Learn from world-renowned dermatology experts at #PDElive27. 🧬 Dive into the latest clinical insights, practical approaches and evolving treatment strategies for pigmentary disorders.🔬 pigmentarydisorders.com
66
🧠 What’s old? What’s new? And what’s actually working in psychiatry? Join leading experts virtually Nov. 10–11 to unpack the latest in schizophrenia, MDD, bipolar disorder & agitation. 💡 Live Q&As + practical insights you can use! mdsc.pe/45L60nM
#Psychupdate26
2
101
💉 LIVE Neurotoxin Demo! 📺 Watch @CoreyHartmanMD and Noelani Gonzalez, MD, FAAD, share expert injection techniques and clinical pearls. 🎟️ Register: SkinOfColorUpdate.com
#SkinOfColorUpdate #Injectables
77
🔥 Advances in prurigo nodularis are changing patient care. 📑 Learn from @drshawnkwatra. 🚨 Register: SkinOfColorUpdate.com
#SkinOfColorUpdate
121
🏠 Full house at Perspectives in Rheumatic Diseases! 🦴 Attendees are diving into the latest research, clinical evidence, and evolving approaches to rheumatologic care. 🧬 From new data to practical takeaways, there’s plenty to discuss at #PRDlive26! 💭
163
A memorable moment at #PRDLive26 🩺
🎓 Founding Co-Chair Daniel E. Furst, MD, alongside Co-Chair Marcy Bolster, MD, and Daniel E. Furst, MD Honorary Lecture Speaker Monique Hinchcliff, MD
Celebrating the experts helping shape the future of rheumatology
180
🧬 ADCs are reshaping breast cancer treatment across subtypes. Join @JavierCortesMD, @RebeccaDSing & @stolaney1 to explore the latest trial data, 🎯 apply biomarker-guided therapies & personalize treatment with novel agents. 🔬 Register today! mdsc.pe/3TKIKni #ESMO
158
🏠 Bring HF decongestion closer to home! Explore SC diuretic initiation, early warning signs 🔍, CKD-informed strategies, and remote monitoring for timely intervention. #HFSA2026 mdsc.pe/3RZd9xv
2
196
💬 IBS-C can disrupt far more than digestion! Explore its real-world burden, discover practical nonpharmacologic strategies, and learn how to select prescription therapies based on what matters most for each patient. 🔎 mdsc.pe/4gbThPC
169
🧬 In MDS, every molecular detail can help shape the treatment path. Explore cytogenetic and 🩸 molecular characteristics, evolving trial data & evidence-based strategies across the disease continuum. 🔬 Turn precision into practice—register today! mdsc.pe/4r4FVcQ
#ASH26
153
🧠 Recurrent stroke carries a profound human burden—but prevention is evolving. Explore patient-relevant evidence for factor XIa inhibitors. 🧬, phase 3 patient profiles & their emerging risk-benefit picture ⚖️ Stay ahead of what’s next 👉 mdsc.pe/461BplZ
162
😴 OSA doesn’t always look like the “typical” patient. Learn to recognize overlooked presentations in primary care, explore the 🩺 clinical benefits of CPAP & tackle barriers that can limit its use. 🌙 Strengthen your OSA strategy—register today! mdsc.pe/4ynljzf #AAFPFMX
1
200
🧬 As anti-HER2 options expand in GEA, toxicity management matters. 🩺 Explore emerging safety profiles, tackle bispecific antibody–associated diarrhea & build individualized monitoring plans. ⚡ Be ready to recognize, manage & triage—register today! mdsc.pe/3SLUk0U
116
PBC treatment checkpoint: 🛑➡️🟢
First-line response falling short? Explore when to advance therapy, how to select second-line options, and 🧬 how to build management around what matters to the patient. 💬 Ready for the next step? Join us! mdsc.pe/4iRKdlN
172